These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7827146)

  • 41. [Resistance avoided, prognosis improved--myocet in AIDS-related non-Hodgkin's lymphoma].
    Pohlmann BK
    Onkologie; 2004 Oct; 27(5):514-5. PubMed ID: 15595188
    [No Abstract]   [Full Text] [Related]  

  • 42. Chemotherapy for non-Hodgkin's lymphoma.
    Brusamolino E
    Curr Opin Oncol; 1989 Oct; 1(1):32-41. PubMed ID: 2489947
    [No Abstract]   [Full Text] [Related]  

  • 43. Non-Hodgkin's lymphomas.
    Theodossiou C; Schwarzenberger P
    Clin Obstet Gynecol; 2002 Sep; 45(3):820-9. PubMed ID: 12370624
    [No Abstract]   [Full Text] [Related]  

  • 44. [Diagnostics, classification and high dose chemotherapy in non Hodgkin's and Hodgkin's lymphoma].
    Nowak WS; Jurczak W; Wójcik M; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():73-9. PubMed ID: 10494187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combined (poly-chemo-radio) therapy of non-Hodgkin's lymphomas].
    Baĭsogolov GD; Shakhtarina SV; Polonskaia NIu; Davydov VA
    Med Radiol (Mosk); 1989 Aug; 34(8):31-6. PubMed ID: 2770444
    [No Abstract]   [Full Text] [Related]  

  • 46. Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
    Dodwell DJ; de Campos ES; Radford JA
    Drugs; 1992 Jul; 44(1):1-8. PubMed ID: 1379906
    [No Abstract]   [Full Text] [Related]  

  • 47. [The treatment of non-Hodgkin's lymphomas taking into account individual sensitivity to the chemical preparations].
    Kindzel'skiĭ LP; Sivkovich SA; Ponomareva OV
    Lik Sprava; 1996; (3-4):104-7. PubMed ID: 9035839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salvage combination chemotherapy with cisplatinum, etoposide and bleomycin in refractory non-Hodgkin's lymphomas.
    Comella P; Abate G; Di Finizio G; Fiore M; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1262-3. PubMed ID: 16312858
    [No Abstract]   [Full Text] [Related]  

  • 50. Cyclophosphamide, mitoxantrone, vincristine and prednisone in the treatment of non-Hodgkin's lymphoma.
    Vorobiof DA; Terblanche AP; Falkson CI; Falkson G
    Oncology; 1988; 45(5):378-9. PubMed ID: 3412747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotherapy in non-Hodgkin's lymphoma during pregnancy.
    Lambert J; Wijermans PW; Dekker GA; Ossenkoppele GJ
    Neth J Med; 1991 Feb; 38(1-2):80-5. PubMed ID: 2030816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851.
    Gottlieb AJ; Anderson JR; Ginsberg SJ; Bloomfield CD; Norton L; Barcos M; Peterson BA; Nissen N; Henderson ES; Holland JF
    Cancer; 1990 Nov; 66(9):1888-96. PubMed ID: 1699653
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of advanced refractory lymphomas with a combination of carmustine, bleomycin, teniposide, dexamethasone, and cisplatin (the BBVDD regimen). An ECOG pilot study.
    Spiers AS; Weens JH; Rowe JM; Smith TJ; Horton J; Gordon LI; Glick JH
    Am J Clin Oncol; 1991 Dec; 14(6):519-25. PubMed ID: 1720279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for the treatment of aggressive non-Hodgkin's lymphoma in elderly patients.
    Veneri D; Zanetti F; Franchini M; Krampera M; Pizzolo G
    Haematologica; 2002 Nov; 87(11):ELT43. PubMed ID: 12414364
    [No Abstract]   [Full Text] [Related]  

  • 56. Cyclophosphamide, epirubicin, vincristine and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
    Comella P; Abate G; Fiore M; Di Finizio G; Polverino W; Muto P; Zarrilli D
    Haematologica; 1988; 73(6):509-12. PubMed ID: 3148514
    [No Abstract]   [Full Text] [Related]  

  • 57. Randomized phase III study for the treatment of advanced indolent non-Hodgkin's lymphomas (NHL) and mantle cell lymphoma: chemotherapy versus chemotherapy plus rituximab.
    Herold M; Dölken G; Fiedler F; Franke A; Freund M; Helbig W; Pasold R
    Ann Hematol; 2003 Feb; 82(2):77-9. PubMed ID: 12601483
    [No Abstract]   [Full Text] [Related]  

  • 58. New chemotherapeutic agents for non-Hodgkin's lymphomas.
    Cheson BD
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):1027-51. PubMed ID: 1718938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of resistant non-Hodgkin's lymphomas with cisplatin, etoposide, vindesine, methotrexate with leucovorin rescue. Greek Lymphoma Research Group.
    Chemioterapia; 1987 Jun; 6(2 Suppl):721-3. PubMed ID: 3509941
    [No Abstract]   [Full Text] [Related]  

  • 60. The influence of maximum supportive care on dose compliance and survival. Single-center analysis of childhood acute lymphoblastic leukemia and non-Hodgkin's-lymphoma treated within 1984-1993.
    Urban C; Benesch M; Lackner H; Schwinger W; Kerbl R; Gadner H
    Klin Padiatr; 1997; 209(4):235-42. PubMed ID: 9293456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.